Skip to main content

Month: June 2022

Bavarian Nordic Conference Call: General Monkeypox Update

COPENHAGEN, Denmark – June 3, 2022 – Bavarian Nordic A/S (OMX: BAVA) will host an investor and analyst conference call on Tuesday, June 7, 2022, at 3:00 pm CEST (9:00 am EDT) to provide a general update on the Company’s business in relation to the ongoing monkeypox outbreak. President & CEO, Paul Chaplin and EVP and CFO, Henrik Juuel will give a presentation covering topics such as the monkeypox disease and the current outbreak, regulatory status and official recommendations on the use of the Company’s smallpox/monkeypox vaccine, and the interactions with countries and organizations worldwide on vaccine supply in both the short and long term and its impact on the Company’s business and guidance. The presentation will be followed by a Q&A session. A live and replay version of the call and relevant slides will be available...

Continue reading

UMH PROPERTIES, INC. TO PARTICIPATE IN NAREIT’S REITWEEK: 2022 INVESTOR CONFERENCE

FREEHOLD, NJ, June 03, 2022 (GLOBE NEWSWIRE) — UMH Properties, Inc. (NYSE:UMH) today announced that Samuel A. Landy, President and Chief Executive Officer, Anna T. Chew, Vice President and Chief Financial Officer, and Eugene W. Landy, Chairman of the Board, are scheduled to participate in Nareit’s REITweek: 2022 Investor Conference, to be held in New York City, at the New York Hilton Midtown. UMH’s senior management team is scheduled to present on Wednesday, June 8, 2022, at 9:30 a.m. Eastern Time. The presentation will be available live via webcast and accessible at the Company’s website, www.umh.reit, in the Upcoming Events section. The webcast replay will be available for 30 days after the presentation. Presentation materials will also be available at the Company’s website homepage. UMH Properties, Inc., which was organized...

Continue reading

Touax: share capital and voting rights at May 31, 2022

REGULATED INFORMATION                Paris, 3 June 2022 5:45 PM YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE TRANSPORTATION Disclosure of Share Capital and Voting Rights Disclosure of Share Capital and Voting Rights pursuant to Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers. Register name of the issuer: TOUAX SCA (Euronext Paris: TOUP)Date Total shares outstanding Total voting rights Total exercisable voting rights*May 31, 2022 7,011,547 8,350,162 8,267,246* excluding rights attached to shares held in treasury **************** TOUAX Group leases out tangible assets (freight railcars, river barges and containers) on a daily basis throughout the world, for its own account and on behalf of third party investors. With €1.1 billion under...

Continue reading

DISCLOSURE OF THE NUMBER OF SHARES FORMING THE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS AS OF 31 MAY 2022  

  French public limited company (société anonyme) with a share capital of €1,491,929,810.00 Registered office : 1973, boulevard de la Défense 92000 Nanterre – France 552 037 806 RCS Nanterre www.vinci.com   DISCLOSURE OF THE NUMBER OF SHARES FORMING THE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS AS OF 31 MAY 2022    Total number of shares 596,771,924Theoretical number of voting rights (including treasury stock) 596,771,924Number of voting rights (excluding treasury stock) 564,895,683  This disclosure is on VINCI web site www.vinci.com (section investors/financial information/regulatory information/7. monthly information concerning the total number of voting rights and shares that make up the company’s capital).Attachment2022 05 31 ddv English version

Continue reading

Valneva to Present and Hold Investor Meetings at the Jefferies US Healthcare Conference

Saint-Herblain (France), June 3, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with institutional investors at the Jefferies Healthcare Conference which will take place from June 8 to 10, 2022 in New York.  Valneva’s Chief Executive Officer Thomas Lingelbach and Chief Financial Officer Peter Bühler will notably discuss the Company’s late-stage vaccine candidates against Lyme disease (VLA15), chikungunya (VLA1553) and COVID-19 (VLA2001). Valneva was recently granted Conditional Marketing Authorization in the United Kingdom for its inactivated COVID-19 vaccine candidate VLA20011 and filed a Marketing Authorization Application with the European Medicines in May 20222. The Company also recently commenced the pre-submission...

Continue reading

Santhera Announces Corporate Calendar Update

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, June 3, 2022 — Santhera Pharmaceuticals (SIX: SANN) has updated its corporate calendar. The Company will publish its 2021 Annual Report on June 10, 2022 and hold its Annual General Meeting on June 30, 2022. SIX Exchange Regulation has permitted Santhera to publish its annual report for the year ended December 31, 2021, on June 10, 2022. Following the successful completion of Santhera’s financing announced on June 2, 2022, Santhera is in the process of completing the 2021 annual report. Also, SIX Exchange Regulation has approved the listing of 15,500,000 existing treasury shares of Santhera as of Tuesday, June 7, 2022. DECISION OF SIX EXCHANGE REGULATION To allow for the finalization of the annual report, SIX Exchange Regulation has granted an extension for the...

Continue reading

Ageas: Transparency notification

Ageas: Transparency notification In accordance with the rules on financial transparency*, Ageas has notified on 3 June 2022 that, on 1 June 2022, its interest has exceeded the statutory threshold of 3% of the shares issued by Ageas. Its current shareholding stands at 3.01%. Reason for the notificationAcquisition or disposal of voting securities or voting rights Notification byA parent undertaking or a controlling person Persons subject to the notification requirementSee annex 1a Date on which the threshold is crossed1 June 2022e Threshold that is crossed (in %)3% shares Denominator189,731,187 Notified detailsSee annex 1 b Chain of controlled undertakings through which the holding is effectively held, if applicableThe full chain of command can be found on https://www.ageas.com/investors/shareholders Additional informationThe shares related...

Continue reading

Sogeclair: Voting rights as at 2022/05/31

SOGECLAIRBusiness corporation with a capital of 3 204 901 EurosHead Office: 7 avenue Albert Durand – 31700 BLAGNAC (France)Tel.: +33 (0)5.61.71.71.71 – www.sogeclair.com335 218 269 R.C.S. TOULOUSE Information concerning the total number of voting rights and shares in the share capitalSection L.233-8 II of French commercial law (“Code de commerce”) and section 223-16 of the general rules of the French Financial Markets Authority (‘“Règlement général de l’Autorité des Marchés Financiers”)DATE Total number of shares in the share capital Total number of voting rights31 May 2022 3,204,901 Total voting rights – brut: 5,355,854    Total voting rights – net*: 5,211,358* net total: total number of voting rights attached to the total number of shares –  shares deprived of voting rights (treasury stock etc.)Attachment...

Continue reading

Assystem: Combined General Meeting of 3 June 2022 – Voting results and dividend for financial year 2021

         Combined General Meeting of June 3rd, 2022Voting results and dividend for financial year 2021 Paris-La Défense, June 3rd, 2022, 17.35 p.m (CET) – Assystem S.A. (ISIN: FR0000074148 – ASY), confirms that its Combined General Meeting was held today, at the Centre de conférences Etoile Saint Honoré located at 21-25 rue Balzac, 75008 Paris, chaired by Mr. Dominique Louis, Chairman and CEO. The quorum was 86.47 % and the General Meeting approved all resolutions submitted to vote except for the fifth one (Approval of related-party agreements). In particular, the General Meeting:approved the parent company and consolidated financial statements for the year ended on December 31st, 2021 and also decided the payment of a dividend of €1.00 per share for the 2021 financial year with the following schedule:6 July 2022: ex-date, 7 July 2022...

Continue reading

Next Hydrogen ranked #1 among publicly traded companies in The Future 50 Fastest-Growing Sustainable Companies in Canada

CALGARY, Alberta, June 03, 2022 (GLOBE NEWSWIRE) — Next Hydrogen Solutions Inc. (the “Company” or “Next Hydrogen“) (TSXV:NXH, OTC:NXHSF), a designer and manufacturer of electrolyzers, is pleased to announce that Corporate Knights, a Canadian media and research  Corp committed to advancing a sustainable economy, has ranked Next Hydrogen first amongst the publicly-traded companies in its  future fastest- growing sustainable companies in Canada ranking. This new ranking from Corporate Knights pinpoints the fastest-growing Canadian companies whose business activities align with the transition to a clean energy economy. “Next Hydrogen is honored to be recognized as the future fastest growing public sustainable company in Canada,” says Raveel Afzaal, President and CEO of Next Hydrogen. “Our revolutionary and scalable electrolyzer cell...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.